Name
Farmatar OÜ
Registry code
14918262
VAT number
EE102237881
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
21.02.2020 (4)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
46461 - Wholesale of medicines and other pharmacy goods
1 346 000 €
-366 000 €
-27%
-
-874 000 €
10
Submitted
No tax arrears
42%
-54%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| ONBord OÜ 14497375 | 20% - 500.00 EUR | - | - | Founder |
| Apteegikaubanduse Hulgimüük OÜ 12590461 | 80% - 2 000.00 EUR | - | - | |
| Jaana Pütsepp 27.09.1966 (58) | - | Board member | - | |
| Maido Mölder 06.02.1982 (42) | - | - | Indirect ownership | Board member |
| Martin Henning 28.08.1975 (49) | - | - | Indirect ownership | Board member |
| Kert Pütsepp 25.04.1992 (32) | - | - | - | Board member |
| AKTSIASELTS INFORTAR 10139414 | - | - | - | Founder |
| 2020 25.06.2021 | 2021 03.10.2022 | 2022 21.06.2023 | 2023 30.06.2024 | |
|---|---|---|---|---|
| Total Revenue | 84 000 € | 2 085 000 € | 1 340 000 € | 1 346 000 € |
| Net profit (loss) for the period | -263 000 € | 105 000 € | -353 000 € | -366 000 € |
| Profit Margin | -313% | 5% | -26% | -27% |
| Current Assets | 241 000 € | 1 024 000 € | 515 000 € | 540 000 € |
| Fixed Assets | 35 000 € | 41 000 € | 134 000 € | 139 000 € |
| Total Assets | 276 000 € | 1 065 000 € | 649 000 € | 679 000 € |
| Current Liabilities | 536 000 € | 1 220 000 € | 1 157 000 € | 1 553 000 € |
| Non Current Liabilities | - | - | - | - |
| Total Liabilities | - | - | - | - |
| Share Capital | - | - | - | - |
| Equity | -260 000 € | -155 000 € | -508 000 € | -874 000 € |
| Employees | 7 | 17 | 22 | 10 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 824 280.72 € | 53 696.2 € | 36 324.16 € | 7 |
| 2023 Q4 | 533 025.49 € | 53 846.39 € | 34 231.94 € | 9 |
| 2023 Q3 | 402 317.86 € | 51 101.02 € | 34 100.09 € | 8 |
| 2023 Q2 | 469 016.34 € | 64 929.97 € | 49 934.13 € | 9 |
| 2023 Q1 | 366 937.97 € | 57 481.77 € | 42 716.32 € | 10 |
| 2022 Q4 | 379 343.41 € | 58 915.2 € | 42 434.31 € | 10 |
| 2022 Q3 | 360 945.23 € | 47 785.13 € | 41 581.61 € | 10 |
| 2022 Q2 | 256 405.12 € | 64 167.88 € | 55 661.52 € | 10 |
| 2022 Q1 | 1 108 022.36 € | 86 952.57 € | 67 115.89 € | 43 |
| 2021 Q4 | 241 694.81 € | 55 505.77 € | 55 805.18 € | 36 |
| 2021 Q3 | 230 163.31 € | 45 896.28 € | 41 697.97 € | 24 |
| 2021 Q2 | 269 526.13 € | 36 383.24 € | 33 756.93 € | 9 |
| 2021 Q1 | 73 517.7 € | 31 441.03 € | 33 283.49 € | 7 |
| 2020 Q4 | 129 615.91 € | 31 905.81 € | 33 469.76 € | 7 |
| 2020 Q3 | 48 099.73 € | 20 158.25 € | 19 400.06 € | 6 |
| 2020 Q2 | - | 507.18 € | 516.69 € | 5 |
| 2020 Q1 | - | - | - | - |
